Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Spiro and cyclic bis-benzylidene proteasome inhibitor for the treatment of cancer, diabetes and neurological disorders

Spiro and cyclic bis-benzylidene proteasome inhibitor for the treatment of cancer, diabetes and neurological disorders

US Patent 10947199 · Granted Mar 16, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

DNA vaccine for human papillomavirus and method for using the same2024
System for the assessment of protease activity2020
Combination therapies for human papillomavirus-associated diseases comprising ad2019
Protein delivery system to generate induced pluripotent stem (iPS) cells or tiss2015
Protein delivery system to generate pluripotent stem (iPS) cells or tissue speci2013
Regulated nucleic acid expression system2011
Regulated nucleic acid expression system2004
Tissue-vectors specific replication and gene expression2003
Methods for stable transduction of cells with hiv-derived viral vectors2003
Vectors for tissue-specific replication2003
Vectors for tissue-specific replication1999